Organogenesis Holdings (ORGO) Invested Capital (2017 - 2024)
Organogenesis Holdings (ORGO) posted quarterly Invested Capital of $6.0 million for Q3 2024, up 120.81% year-over-year from $2.7 million in Q4 2023, and up 3.58% quarter-over-quarter from $5.8 million in Q2 2024.
Organogenesis Holdings (ORGO) Invested Capital (2017 - 2024) Analysis & Trends
Organogenesis Holdings' Invested Capital history runs 8 years deep, the most recent figure standing at $6.0 million for Q3 2024.
- In Q3 2024, Invested Capital rose 120.81% year-over-year to $6.0 million; the TTM figure through Jun 2025 stood at $6.0 million (down 69.31% YoY), while the FY2023 annual figure was $5.5 million, up 20.89% from the prior year.
- Invested Capital for Q3 2024 stood at $6.0 million, up from $5.8 million in the prior quarter.
- The five-year high for Invested Capital was $11.7 million in Q3 2020, with the low at $101000.0 in Q1 2021.
- The 5-year median for Invested Capital is $4.5 million (2022), against an average of $4.4 million.
- The sharpest annual moves came in 2021 and 2022: Invested Capital slumped 95.36% in 2021, then jumped 2995.05% in 2022.
- Organogenesis Holdings' Invested Capital stood at $4.3 million in 2020, then plunged by 95.36% to $200000.0 in 2021, then surged by 2169.0% to $4.5 million in 2022, then rose by 20.89% to $5.5 million in 2023, then increased by 8.71% to $6.0 million in 2024.
- Business Quant data shows ORGO's Invested Capital at $6.0 million in Q3 2024, $5.8 million in Q2 2024, and $5.5 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 630.00 Mn |
| 10 | Organogenesis Holdings | 240.62 Mn | 193.78 Mn | 20.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 5.96 Mn |
| Jun 30, 2024 | 5.76 Mn |
| Mar 31, 2024 | 5.49 Mn |
| Dec 31, 2023 | 5.49 Mn |
| Sep 30, 2023 | 2.70 Mn |
| Jun 30, 2023 | 5.48 Mn |
| Mar 31, 2023 | 5.01 Mn |
| Dec 31, 2022 | 4.54 Mn |
| Sep 30, 2022 | 5.00 Mn |
| Jun 30, 2022 | 3.60 Mn |
| Mar 31, 2022 | 3.13 Mn |
| Dec 31, 2021 | 200,000.00 |
| Sep 30, 2021 | 3.10 Mn |
| Jun 30, 2021 | 4.31 Mn |
| Mar 31, 2021 | 101,000.00 |
| Dec 31, 2020 | 4.31 Mn |
| Sep 30, 2020 | 11.67 Mn |
| Jun 30, 2020 | 6.67 Mn |
| Mar 31, 2020 | 1.67 Mn |
| Dec 31, 2019 | 4.31 Mn |